Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer

NCT04402151 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC
RADIATION: Stereotactic Body Radiation Therapy (SBRT)

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]
[object Object]